You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

48 search results for: disease progression

Type 2 Inflammatory <b>Disease</b> Trajectories: Unraveling Patterns of <b>Disease</b> Development and Burden in Pediatric Patients

expert video

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in Pediatric Patients

15 min

Type 2 Inflammation

Dr. Leonard Bacharier presents potential disease trajectories and burden for pediatric patients with type 2 inflammatory diseases.

New Perspectives on <b>Disease</b> Modification in Atopic Dermatitis

expert video

New Perspectives on Disease Modification in Atopic Dermatitis

48 min

Dermatology

An exploration into the concept and potential of disease modification through therapeutic interventions in AD.

Exploring The Concept of <b>Disease</b> Modification in Atopic Dermatitis

expert video

Exploring The Concept of Disease Modification in Atopic Dermatitis

13 min

Dermatology

Exploring the concept of disease modification and related pathomechanisms in atopic dermatitis.

New Perspectives on <b>Disease</b> Modification in Atopic Dermatitis - Panel Discussion

expert video

New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion

10 min

Dermatology

Panel discussion exploring what disease modification could involve in atopic dermatitis.

The Impact of Advanced Systemic Therapies on <b>Disease</b> Control and Potential Remission in Atopic Dermatitis

expert video

The Impact of Advanced Systemic Therapies on Disease Control and Potential Remission in Atopic Dermatitis

10 min

Dermatology

Exploring the concept of disease modification relating to therapeutic interventions with targeted systemic therapies in atopic dermatitis.

expert video

UEGW 2023 | Burden of EoE and Multidimensional Assessment of Disease

10 min

Gastroenterology

Dr. Christoper Ma explores the burden of disease in EoE and the multiple dimensions of disease to assess in patients with EoE.

Importance of Assessing Multiple <b>Disease</b> Domains in EoE

expert video

Importance of Assessing Multiple Disease Domains in EoE

2 min

Gastroenterology

Prof. Arjan Bredenoord and Dr. Evan Dellon emphasize the need to assess multiple disease domains to get the complete picture of patients’ EoE.

UEGW 2023 | Expanding Horizons in EoE: The Journey to Long-term <b>Disease</b> Control

expert video

UEGW 2023 | Expanding Horizons in EoE: The Journey to Long-term Disease Control

46 min

Gastroenterology

Join Prof. Christoph Schlag and Dr. Christoper Ma for an educational presentation about the journey to long-term disease control in EoE.

expert video

Type 2 Inflammation in EoE and Impact on Disease Burden

20 min

Gastroenterology

Dr. Seema Aceves discusses the role of type 2 inflammation in EoE pathophysiology and disease burden.

expert video

Can early intervention modify the course of AD?

5 min

Dermatology

Dr. Amy Paller emphasizes that early intervention in children can alter disease progression. Depending on the severity, this can be achieved with topical interventions or systemic therapies.

Type 2 Inflammation as the Common Thread in Multiple <b>Disease</b>s

videoanimation

Type 2 Inflammation as the Common Thread in Multiple Diseases

5 min

Type 2 Inflammation

This video highlights type 2 inflammation as the common thread that links AD, asthma, CRSwNP, and EoE.

Infographic

Skin Barrier Dysfunction and Increased Risk of Allergen Sensitization May Impact Atopic March in Atopic Dermatitis (AD)

5 min

Dermatology

An infographic exploring the process of allergen sensitization and the impact it may have on the development of atopic comorbidities in children with AD.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: DenmarkChange country/region